Literature DB >> 22618691

The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis.

Arthur J L Cooper1.   

Abstract

In the brain, glutamine synthetase (GS), which is located predominantly in astrocytes, is largely responsible for the removal of both blood-derived and metabolically generated ammonia. Thus, studies with [(13)N]ammonia have shown that about 25 % of blood-derived ammonia is removed in a single pass through the rat brain and that this ammonia is incorporated primarily into glutamine (amide) in astrocytes. Major pathways for cerebral ammonia generation include the glutaminase reaction and the glutamate dehydrogenase (GDH) reaction. The equilibrium position of the GDH-catalyzed reaction in vitro favors reductive amination of α-ketoglutarate at pH 7.4. Nevertheless, only a small amount of label derived from [(13)N]ammonia in rat brain is incorporated into glutamate and the α-amine of glutamine in vivo. Most likely the cerebral GDH reaction is drawn normally in the direction of glutamate oxidation (ammonia production) by rapid removal of ammonia as glutamine. Linkage of glutamate/α-ketoglutarate-utilizing aminotransferases with the GDH reaction channels excess amino acid nitrogen toward ammonia for glutamine synthesis. At high ammonia levels and/or when GS is inhibited the GDH reaction coupled with glutamate/α-ketoglutarate-linked aminotransferases may, however, promote the flow of ammonia nitrogen toward synthesis of amino acids. Preliminary evidence suggests an important role for the purine nucleotide cycle (PNC) as an additional source of ammonia in neurons (Net reaction: L-Aspartate + GTP + H(2)O → Fumarate + GDP + P(i) + NH(3)) and in the beat cycle of ependyma cilia. The link of the PNC to aminotransferases and GDH/GS and its role in cerebral nitrogen metabolism under both normal and pathological (e.g. hyperammonemic encephalopathy) conditions should be a productive area for future research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618691      PMCID: PMC3490058          DOI: 10.1007/s11064-012-0803-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  93 in total

1.  Control of the redox state of the pyridine nucleotides in the rat cerebral cortex. Effect of electroshock-induced seizures.

Authors:  D C Howse; T E Duffy
Journal:  J Neurochem       Date:  1975-05       Impact factor: 5.372

Review 2.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

3.  Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine.

Authors:  Renata Leke; Lasse K Bak; Malene Anker; Torun M Melø; Michael Sørensen; Susanne Keiding; Hendrik Vilstrup; Peter Ott; Luis V Portela; Ursula Sonnewald; Arne Schousboe; Helle S Waagepetersen
Journal:  Neurotox Res       Date:  2010-05-18       Impact factor: 3.911

4.  Metabolism of [13N]ammonia in rat lung.

Authors:  Arthur J L Cooper; Barry R Freed
Journal:  Neurochem Int       Date:  2005-07       Impact factor: 3.921

5.  Factors that affect the uptake of ammonia by the brain: the blood-brain pH gradient.

Authors:  A H Lockwood; R D Finn; J A Campbell; T B Richman
Journal:  Brain Res       Date:  1980-01-13       Impact factor: 3.252

6.  Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.

Authors:  Hanan Mardini; Fiona E Smith; Christopher O Record; Andrew M Blamire
Journal:  J Hepatol       Date:  2011-02-03       Impact factor: 25.083

Review 7.  13N as a tracer for studying glutamate metabolism.

Authors:  Arthur J L Cooper
Journal:  Neurochem Int       Date:  2010-11-23       Impact factor: 3.921

8.  Cerebral metabolic compartmentation. Estimation of glucose flux via pyruvate carboxylase/pyruvate dehydrogenase by 13C NMR isotopomer analysis of D-[U-13C]glucose metabolites.

Authors:  A Lapidot; A Gopher
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

9.  Cataplerotic TCA cycle flux determined as glutamate-sustained oxygen consumption in primary cultures of astrocytes.

Authors:  Leif Hertz; Elna Hertz
Journal:  Neurochem Int       Date:  2003 Sep-Oct       Impact factor: 3.921

10.  Compartmentalized Cerebral Metabolism of [1,6-(13)C]Glucose Determined by in vivo (13)C NMR Spectroscopy at 14.1 T.

Authors:  João M N Duarte; Bernard Lanz; Rolf Gruetter
Journal:  Front Neuroenergetics       Date:  2011-06-06
View more
  42 in total

Review 1.  The Astrocyte: Powerhouse and Recycling Center.

Authors:  Bruno Weber; L Felipe Barros
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-02-13       Impact factor: 10.005

2.  Postictal ammonia as a biomarker for electrographic convulsive seizures: A prospective study.

Authors:  Rawan Albadareen; Gary Gronseth; Patrick Landazuri; Jianghua He; Nancy Hammond; Utku Uysal
Journal:  Epilepsia       Date:  2016-06-01       Impact factor: 5.864

Review 3.  In vivo N-15 MRS study of glutamate metabolism in the rat brain.

Authors:  Keiko Kanamori
Journal:  Anal Biochem       Date:  2016-08-28       Impact factor: 3.365

4.  Energy metabolism of synaptosomes from different neuronal systems of rat cerebellum during aging: a functional proteomic characterization.

Authors:  Federica Ferrari; Antonella Gorini; Roberto Federico Villa
Journal:  Neurochem Res       Date:  2014-11-30       Impact factor: 3.996

Review 5.  In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Authors:  Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2012-12-21       Impact factor: 3.584

6.  The effect of pH and ADP on ammonia affinity for human glutamate dehydrogenases.

Authors:  Ioannis Zaganas; Kamilla Pajęcka; Camilla Wendel Nielsen; Arne Schousboe; Helle S Waagepetersen; Andreas Plaitakis
Journal:  Metab Brain Dis       Date:  2013-02-20       Impact factor: 3.584

Review 7.  Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.

Authors:  Arthur J L Cooper
Journal:  Metab Brain Dis       Date:  2012-10-13       Impact factor: 3.584

Review 8.  Imine reductases: a comparison of glutamate dehydrogenase to ketimine reductases in the brain.

Authors:  André Hallen; Joanne F Jamie; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2013-01-12       Impact factor: 3.996

9.  The negative impact of α-ketoglutarate dehydrogenase complex deficiency on matrix substrate-level phosphorylation.

Authors:  Gergely Kiss; Csaba Konrad; Judit Doczi; Anatoly A Starkov; Hibiki Kawamata; Giovanni Manfredi; Steven F Zhang; Gary E Gibson; M Flint Beal; Vera Adam-Vizi; Christos Chinopoulos
Journal:  FASEB J       Date:  2013-03-08       Impact factor: 5.191

Review 10.  Nutritional assessment in cirrhotic patients with hepatic encephalopathy.

Authors:  Fernando Gomes Romeiro; Laís Augusti
Journal:  World J Hepatol       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.